Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Mr. Rajeev ModiExec. VP of U.S. Pet Health & Global Digital Transformation | 4,91k | 99,94k | Kauf | 20,35 | 160,81k | 3,15% |
| 2026-05-15 | Mr. Jeffrey N. SimmonsPresident, CEO & Director | 4,97k | 99,84k | Kauf | 20,09 | 1,87M | 0,27% |
| 2026-04-01 | Dr. Ellen de BrabanderExec. VP of Research, Development & Regulatory Affairs | -20,29k | 469,06k | Sale to Issuer | 23,12 | 211,13k | -8,77% |
| 2026-03-03 | Mr. Rajeev ModiExec. VP of U.S. Pet Health & Global Digital Transformation | -4,39k | 109,27k | Sale to Issuer | 24,88 | 155,90k | -2,74% |
| 2026-03-03 | Ms. Shiv O'NeillExec. VP, General Counsel & Corporate Secretary | -4,74k | 117,88k | Sale to Issuer | 24,88 | 83,83k | -5,35% |
| 2026-03-03 | Mr. Jeffrey N. SimmonsPresident, CEO & Director | -37,90k | 942,90k | Sale to Issuer | 24,88 | 1,86M | -2,00% |
| 2026-03-03 | Mr. Timothy J. BettingtonExec. VP of Center of Strategic Growth | -4,70k | 116,81k | Sale to Issuer | 24,88 | 105,88k | -4,25% |
| 2026-03-03 | Dr. Ramiro Martin CabralExec. VP & President of Elanco International | -6,49k | 161,52k | Sale to Issuer | 24,88 | 224,13k | -2,81% |
| 2026-03-03 | Dr. Jose Manuel Correia de SimasExec. VP of US Farm Animal Business | -3,37k | 83,87k | Sale to Issuer | 24,88 | 71,54k | -4,50% |
| 2026-03-03 | Dr. Ellen de BrabanderExec. VP of Research, Development & Regulatory Affairs | -8,26k | 205,56k | Sale to Issuer | 24,88 | 190,43k | -4,16% |
| 2026-03-03 | Mr. David S. KinardExec. VP of HR, Corporate Communications & Administration | -3,43k | 85,41k | Sale to Issuer | 24,88 | 184,86k | -1,82% |
| 2026-03-03 | Ms. Grace McArdleExec. VP of Manufacturing & Quality | -4,32k | 107,53k | Sale to Issuer | 24,88 | 103,71k | -4,00% |
| 2026-03-03 | Mr. James M. MeerSenior VP & CAO | -1,39k | 34,56k | Sale to Issuer | 24,88 | 66,73k | -2,04% |
| 2026-03-01 | Mr. James M. MeerSenior VP & CAO | -4,79k | 126,38k | Sale to Issuer | 26,40 | 47,74k | -9,11% |
| 2026-03-01 | Mr. Rajeev ModiExec. VP of U.S. Pet Health & Global Digital Transformation | -19,38k | 511,50k | Sale to Issuer | 26,40 | 110,80k | -14,88% |
| 2026-03-01 | Mr. Jeffrey N. SimmonsPresident, CEO & Director | -229,98k | 6,07M | Sale to Issuer | 26,40 | 1,81M | -11,27% |
| 2026-03-01 | Dr. Jose Manuel Correia de SimasExec. VP of US Farm Animal Business | -9,88k | 260,91k | Sale to Issuer | 26,40 | 67,54k | -12,76% |
| 2026-03-01 | Dr. Ramiro Martin CabralExec. VP & President of Elanco International | -30,15k | 795,96k | Sale to Issuer | 26,40 | 215,89k | -12,25% |
| 2026-03-01 | Mr. David S. KinardExec. VP of HR, Corporate Communications & Administration | -15,38k | 405,95k | Sale to Issuer | 26,40 | 180,92k | -7,83% |
| 2026-03-01 | Ms. Grace McArdleExec. VP of Manufacturing & Quality | -12,34k | 325,70k | Sale to Issuer | 26,40 | 108,03k | -10,25% |
| 2026-03-01 | Ms. Shiv O'NeillExec. VP, General Counsel & Corporate Secretary | -13,11k | 346,13k | Sale to Issuer | 26,40 | 88,57k | -12,89% |
| 2026-03-01 | Dr. Ellen de BrabanderExec. VP of Research, Development & Regulatory Affairs | -46,28k | 1,22M | Sale to Issuer | 26,40 | 181,84k | -20,29% |
| 2026-03-01 | Mr. Timothy J. BettingtonExec. VP of Center of Strategic Growth | -18,10k | 477,79k | Sale to Issuer | 26,40 | 100,26k | -15,29% |
| 2025-12-19 | Mr. Roy David HooverInsider | -60,00k | 0,00 | Other Disposition | - | 180,92k | -24,90% |
| 2025-12-12 | Mr. Lawrence E. KurziusIndependent Chairman | 10,00k | 213,00k | Kauf | 21,30 | 40,00k | 33,33% |
| 2025-12-11 | Mr. Rajeev ModiExec. VP of U.S. Pet Health & Global Digital Transformation | 4,50k | 95,99k | Kauf | 21,33 | 73,47k | 6,52% |
| 2025-12-11 | Mr. Robert M. VanHimbergenExec. VP & CFO | 6,95k | 150,43k | Kauf | 21,64 | 14,38k | 93,59% |
| 2025-12-11 | Mr. Jeffrey N. SimmonsPresident, CEO & Director | 22,00k | 478,50k | Kauf | 21,75 | 1,87M | 1,19% |
| 2025-07-03 | Mr. James M. MeerSenior VP & CAO | -1,16k | 17,00k | Sale to Issuer | 14,64 | 34,37k | -3,27% |
| 2025-07-03 | Ms. Grace McArdleExec. VP of Manufacturing & Quality | -4,35k | 63,63k | Sale to Issuer | 14,64 | 76,05k | -5,41% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
